Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers.
Engelman JA; Chen L; Tan X; Crosby K; Guimaraes AR; Upadhyay R; Maira M; McNamara K; Perera SA; Song Y; Chirieac LR; Kaur R; Lightbown A; Simendinger J; Li T; Padera RF; García-Echeverría C; Weissleder R; Mahmood U; Cantley LC; Wong KK; Nature Medicine, 2008, vol. 14, issue 12, p 1351, ISSN 1546170x. ISBN 1546170x.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef